Alector vs EyeGate Pharmaceuticals
Alector vs EyeGate Pharmaceuticals, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alector is on 55/100 and EyeGate Pharmaceuticals on 32/100.
Where each one leads
Alector
- our overall score: 55/100 against 32/100
- agent readiness: 50/100 against 39/100
- domain rating: 54/100 against 34/100
- funding raised: $163M against $45.5M
EyeGate Pharmaceuticals
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Alector | EyeGate Pharmaceuticals |
|---|---|---|
| What it is | Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases. | Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B | B2C | B2B2C | B2G |
| Offering | Platform | Software | hardware | services | marketplace | platform |
| Founded | 2013 | 2000 |
| Headquarters | South San Francisco, United States | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alector | EyeGate Pharmaceuticals |
|---|---|---|
| Employees | 151 | Not published |
| Total funding | $163M | $45.5M |
| Latest round | Series E | Debt |
| LinkedIn followers | 20,574 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alector | EyeGate Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 32/100 |
| Traction | 60/100 | 38/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 32/100 | 5/100 |
| Quality | 58/100 | 35/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 54/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alector | EyeGate Pharmaceuticals |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Google Analytics 4, Google Tag Manager |
Alector vs EyeGate Pharmaceuticals: common questions
Which is better, Alector or EyeGate Pharmaceuticals?
On our 0-100 score Alector rates higher (55/100 against 32/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Alector and EyeGate Pharmaceuticals compare on the numbers?
Alector leads on our overall score (55/100 against 32/100), agent readiness (50/100 against 39/100), domain rating (54/100 against 34/100), funding raised ($163M against $45.5M).
Read the full Alector review and pricing or the EyeGate Pharmaceuticals review and pricing. You can also browse other Alector alternatives we track.